Delvincourt C, Patey M, Flament J B, Suarez H G, Larbre H, Jardillier J C, Delisle M J
Institut Jean Godinot, Reims, France.
Clin Biochem. 1996 Jun;29(3):267-71. doi: 10.1016/0009-9120(96)00006-9.
To investigate the presence of ret and trk proto-oncogene rearrangements in thyroid tumors.
High-molecular-weight DNA was extracted from 36 thyroid tumors (1 multinodular goiter, 14 follicular adenomas, 16 papillary carcinomas, 1 lymph node metastasis of a papillary carcinoma, 1 follicular carcinoma, and 3 medullary carcinomas) and 22 adjacent tissues. Southern blot analysis was performed after digestion with EcoR1 or BamH1, using specific probes for ret and trk.
Only 2 ret rearrangements were found in 2 papillary carcinomas (overall frequency: 6%; papillary carcinoma frequency: 13%). All normal or tumor samples were negative for the presence of a trk rearrangement.
The previous data from the literature are highly conflicting, ranging from 0 to 30% of activation. Our results could be, therefore, classified as medium between these extreme values. It seems, therefore, that genetic and/or geographical factors could play a role in ret and trk proto-oncogene activation.
研究甲状腺肿瘤中ret和trk原癌基因重排的情况。
从36例甲状腺肿瘤(1例结节性甲状腺肿、14例滤泡性腺瘤、16例乳头状癌、1例乳头状癌淋巴结转移、1例滤泡状癌和3例髓样癌)及22例相邻组织中提取高分子量DNA。用EcoR1或BamH1消化后进行Southern印迹分析,使用ret和trk的特异性探针。
仅在2例乳头状癌中发现2例ret重排(总频率:6%;乳头状癌频率:13%)。所有正常或肿瘤样本的trk重排均为阴性。
文献中的先前数据存在高度冲突,激活率从0%到30%不等。因此,我们的结果可归类于这些极端值之间的中等水平。因此,似乎遗传和/或地理因素可能在ret和trk原癌基因激活中起作用。